JPRN-UMIN000011470已完成4 期
Effect of alogliptin , a DPP-4 inhibitor, on markers of lipid metabolism in type 2 diabetic patients - Effect of alogliptin , a DPP-4 inhibitor, on markers of lipid metabolism in type 2 diabetic patients
ara Hospital Kinki University Faculty of Medicine0 个研究点目标入组 50 人开始时间: 2013年8月13日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
The presentation at the 55th Japan Diabetes Society Annual Scientific Meeting
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients receiving insulin therapy; severe liver or renal dysfunction; patients with hypersensitivity to alogliptin; patients that had their hypoglycemic agents changed within three months; pregnant women or breast-feeding mothers; and excessive alcohol drinkers.
研究者
相似试验
撤回
1 期
The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder PatientsMajor Depressive DisorderNCT04410341Sadat City University100
已完成
3 期
Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular GeometryLeft Ventricular Systolic DysfunctionDiabetes Mellitus, Type 2NCT02851745Heart Care Foundation188
已完成
不适用
The impact of DPP-4 inhibitor on daily glucose profile and coronary plaque character in impaired glucose tolerance patients with coronary artery diseasepatients with coronary artery disease and impaired glucose tolerance (IGT)JPRN-UMIN000008620Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine24
已完成
3 期
Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2DType 2 DiabetesNCT01937598Michael A. Nauck16
已完成
2 期
Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes PatientsPharmacological ActionNCT03359590Profil Institut für Stoffwechselforschung GmbH20